Cosmo Bio Company,Limited Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2,643	2,747	2,393	2,826	3,036	3,255
Short-Term Investments	599	199	300	199	-	300
Cash & Short-Term Investments	3,242	2,946	2,693	3,025	3,036	3,555
Cash Growth	29.84%	9.40%	-10.97%	-0.36%	-14.60%	9.08%
Accounts Receivable	3,368	3,085	3,002	2,851	2,798	2,710
Receivables	3,368	3,085	3,002	2,851	2,798	2,710
Inventory	971	1,100	1,065	1,038	1,134	863
Other Current Assets	242	310	469	188	168	182
Total Current Assets	7,823	7,441	7,229	7,102	7,136	7,310
Property, Plant & Equipment	829	862	701	572	577	599
Long-Term Investments	3,720	4,144	3,592	3,013	2,397	1,954
Other Intangible Assets	165	167	162	155	171	182
Long-Term Deferred Tax Assets	-	46	37	29	31	25
Other Long-Term Assets	2	2	2	1	1	2
Total Assets	12,539	12,662	11,723	10,872	10,313	10,072
Accounts Payable	753	806	747	639	573	592
Short-Term Debt	20	20	20	20	20	20
Current Income Taxes Payable	107	439	203	294	242	319
Other Current Liabilities	337	157	196	170	203	162
Total Current Liabilities	1,217	1,422	1,166	1,123	1,038	1,093
Pension & Post-Retirement Benefits	650	655	618	555	507	501
Long-Term Deferred Tax Liabilities	-	523	311	87	66	92
Other Long-Term Liabilities	625	107	74	83	86	68
Total Liabilities	2,492	2,707	2,169	1,848	1,697	1,754
Common Stock	918	918	918	918	918	918
Additional Paid-In Capital	1,267	1,267	1,263	1,261	1,260	1,258
Retained Earnings	5,961	5,880	5,891	5,805	5,560	5,274
Treasury Stock	-379	-379	-317	-194	-216	-239
Comprehensive Income & Other	1,690	1,687	1,212	653	529	575
Total Common Equity	9,457	9,373	8,967	8,443	8,051	7,786
Minority Interest	590	582	587	581	565	532
Shareholders' Equity	10,047	9,955	9,554	9,024	8,616	8,318
Total Liabilities & Equity	12,539	12,662	11,723	10,872	10,313	10,072
Total Debt	20	20	20	20	20	20
Net Cash (Debt)	3,222	2,926	2,673	3,005	3,016	3,535
Net Cash Growth	30.08%	9.46%	-11.05%	-0.36%	-14.68%	9.14%
Net Cash Per Share	567.47	514.49	459.61	515.57	519.52	608.56
Filing Date Shares Outstanding	5.67	5.67	5.71	5.84	5.81	5.79
Total Common Shares Outstanding	5.67	5.67	5.73	5.84	5.81	5.79
Working Capital	6,606	6,019	6,063	5,979	6,098	6,217
Book Value Per Share	1667.10	1651.94	1564.87	1446.87	1384.92	1344.30
Tangible Book Value	9,292	9,206	8,805	8,288	7,880	7,604
Tangible Book Value Per Share	1638.01	1622.50	1536.60	1420.30	1355.51	1312.88